Genomic profile of a secretory breast cancer with an ETV6–NTRK3 duplication
暂无分享,去创建一个
Robin L. Jones | A. Ashworth | J. Reis-Filho | K. Fenwick | A. Mackay | D. Tan | R. Jones | R. Vatcheva | K. Savage | M. Lambros | N. Tamber | M. Lambros | David S.P. Tan | Narinder Tamber
[1] D. Berney,et al. Duplication of the fusion of TMPRSS 2 to ERG sequences identifies fatal human prostate cancer , 2009 .
[2] A. Ashworth,et al. The genomic profile of HER2‐amplified breast cancers: the influence of ER status , 2008, The Journal of pathology.
[3] M. Lambros,et al. ESR1 amplification in endometrial carcinomas: hope or hyperbole? , 2008, The Journal of pathology.
[4] A. Ashworth,et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast , 2008, The Journal of pathology.
[5] A. Ashworth,et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas , 2008, The Journal of pathology.
[6] Paul D. Levey,et al. ESR1 gene amplification in breast cancer: a common phenomenon? , 2008, Nature Genetics.
[7] Anne Vincent-Salomon,et al. ESR1 gene amplification in breast cancer: a common phenomenon? , 2008, Nature Genetics.
[8] I. Ellis,et al. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes , 2008, Histopathology.
[9] Alan Mackay,et al. Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines , 2008, Laboratory Investigation.
[10] J Cuzick,et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer , 2008, Oncogene.
[11] E. Resetkova,et al. A Large, Fungating Breast Mass , 2009 .
[12] O. Lingjaerde,et al. ESR1 gene amplification in breast cancer: a common phenomenon? , 2008, Nature Genetics.
[13] D. Birnbaum,et al. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer , 2007, Oncogene.
[14] A. Ashworth,et al. Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour , 2007, The Journal of pathology.
[15] Alan Mackay,et al. Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation , 2007, Laboratory Investigation.
[16] S. Vieni,et al. Secretory breast carcinoma with metastatic sentinel lymph node , 2006, World journal of surgical oncology.
[17] Kenny Q. Ye,et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.
[18] K Fenwick,et al. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse , 2006, The Journal of pathology.
[19] E. Resetkova,et al. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. , 2006, Archives of pathology & laboratory medicine.
[20] A. Ashworth,et al. Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization , 2006, Laboratory Investigation.
[21] D. Amott,et al. Secretory Carcinoma of the Breast , 2006, The breast journal.
[22] A. Ashworth,et al. Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells , 2006, Journal of Clinical Pathology.
[23] Shridar Ganesan,et al. X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.
[24] P. Nederlof,et al. A multiplex PCR predictor for aCGH success of FFPE samples , 2005, British Journal of Cancer.
[25] A. Hagemeijer,et al. Fusion of ETV 6 to MDS 1 / EVIJ as a Result of t ( 3 ; 12 ) ( q 26 ; p 13 ) in Myeloproliferative Disorders , 2006 .
[26] J. Bourhis,et al. Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia. , 2005, Cancer genetics and cytogenetics.
[27] A. Aventín,et al. Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia. , 2005, Cancer genetics and cytogenetics.
[28] D. Birnbaum,et al. ETV6 gene rearrangements in invasive breast carcinoma , 2005, Genes, chromosomes & cancer.
[29] A. Ashworth,et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity , 2005, The Journal of pathology.
[30] K. Tascilar,et al. Secretory Carcinoma of the Breast , 2005, Oncology.
[31] D. Gallardo-Rincón,et al. Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature , 2005, World journal of surgical oncology.
[32] P. Sorensen,et al. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. , 2005, Seminars in cancer biology.
[33] S. Chon,et al. Secretory carcinoma of the breast diagnosed by fine needle aspiration. , 2005, Acta cytologica.
[34] F. Aranda,et al. Secretory carcinoma of the male breast: Correlation of aspiration cytology and pathology , 2005, Diagnostic cytopathology.
[35] Kyung-Ja Cho,et al. Breast mass in a 3-year-old girl: differentiation of secretory carcinoma versus abnormal thelarche by fine needle aspiration biopsy. , 2005, Surgery.
[36] Jane Fridlyand,et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. , 2005, Human molecular genetics.
[37] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[38] S. Bond,et al. Secretory carcinoma in a 9‐year‐old girl , 2004, Diagnostic cytopathology.
[39] Z. Szentirmay,et al. Secretory breast cancer in a 7.5-year old boy. , 2004, Breast.
[40] F. Pardal,et al. Secretory breast carcinoma--case report and review of the medical literature. , 2004, Breast.
[41] T. B. Culas,et al. Secretory carcinoma of breast in a 17-year-old male , 2004, World journal of surgical oncology.
[42] P. Sorensen,et al. A fluorescence in situ hybridization study of ETV6‐NTRK3 fusion gene in secretory breast carcinoma , 2004, Genes, chromosomes & cancer.
[43] A. Seki,et al. Secretory Breast Carcinoma With Extensive Intraductal Component: Case Report , 2004, Ultrastructural pathology.
[44] P. Sorensen,et al. Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry. , 2003, Human pathology.
[45] B. Moon,et al. Secretory carcinoma of the breast , 2003, Journal of clinical ultrasound : JCU.
[46] M. Hirokawa,et al. Secretory Carcinoma of the Breast with a Cystically Dilated Intraductal Component: Report of a Case , 2003, Surgery Today.
[47] M. Miyazaki,et al. Phyllodes tumor arising in ectopic breast tissue of the axilla , 2003, Breast cancer.
[48] C. Timmons,et al. ETV6-NTRK3--Trk-ing the primary event in human secretory breast cancer. , 2002, Cancer cell.
[49] P. Sorensen,et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. , 2002, Cancer cell.
[50] T. Sano,et al. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma? , 2002, Histopathology.
[51] M. Teixeira,et al. Cytogenetic clues to breast carcinogenesis , 2002, Genes, chromosomes & cancer.
[52] S. Shin,et al. Invasive secretory (juvenile) carcinoma arising in ectopic breast tissue of the axilla. , 2001, Archives of pathology & laboratory medicine.
[53] P. Sorensen,et al. Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias. , 2001, Medical and pediatric oncology.
[54] P. Jhabvala,et al. Cytogenetic and Molecular Characterization of a Congenital Mesoblastic Nephroma , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[55] M. Roussel,et al. The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity , 2000, Molecular and Cellular Biology.
[56] H. Herz,et al. Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: case report and review of the literature. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[57] J. F. Magee,et al. Breast cancer in a 6-year-old child. , 2000, Journal of pediatric surgery.
[58] A. Causse,et al. At least five regions of imbalance on 6q in breast tumors, combining losses and gains , 2000, Genes, chromosomes & cancer.
[59] K. Tanaka,et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). , 1999, Blood.
[60] J. Goldman,et al. Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12). , 1999, Blood.
[61] J. Goldman,et al. Fusion of ETV 6 to the Caudal-Related Homeobox Gene CDX 2 in Acute Myeloid Leukemia , 1999 .
[62] F. Lemonnier,et al. Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. , 1998, The Journal of clinical investigation.
[63] M. Höglund,et al. ETV6/ABL fusion is rare in Ph-negative chronic myeloid disorders , 1998, Leukemia.
[64] P. Sorensen,et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma , 1998, Nature Genetics.
[65] F. Lemonnier,et al. Cytotoxic T Cell Response against the Chimeric ETV 6-AML 1 Protein in Childhood Acute Lymphoblastic Leukemia , 1998 .
[66] D. Birnbaum,et al. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. , 1997, Cancer research.
[67] P. Marynen,et al. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. , 1997, Blood.
[68] P. Marynen,et al. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. , 1997, Cancer research.
[69] C. Theillet,et al. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[70] N. Takahashi,et al. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia. , 1996, Cancer genetics and cytogenetics.
[71] C. Mathew,et al. Loss of heterozygosity of the oestrogen receptor gene in breast cancer. , 1995, British Journal of Cancer.
[72] R. Bruzzone,et al. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapsed in advanced phases of the disease after allogeneic bone marrow transplantation. , 1991, Cancer genetics and cytogenetics.
[73] M. Cranor,et al. Secretory carcinoma of the breast. , 1991, Archives of pathology & laboratory medicine.
[74] D. Jenkins,et al. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis , 1989, Histopathology.
[75] R. Zaino,et al. Juvenile secretory carcinoma of the breast. , 1985, Journal of pediatric surgery.
[76] F. Stewart,et al. Breast carcinoma in children. , 1966, JAMA.
[77] J. de Grouchy,et al. [DUPLICATION OF A PH CHROMOSOME AND SUGGESTION OF CLONAL EVOLUTION IN CHRONIC MYELOCYTIC LEUKEMIA IN ACUTE TRANSFORMATION]. , 1965, Nouvelle revue francaise d'hematologie.